In RBI’s language, the positive externalities of G-SAP operations need to be seen in the context of those segments of the financial markets that rely on the G-Sec yield curve as a pricing benchmark. By Rohit Chawla As we approach April 15, 2021, the day when the Reserve Bank of India (RBI) will make the
Opinion
Vaccine manufacturing is a complex process that needs high-quality assurance and tests for every batch. By Amitabh Kant With over 1.6 lakh new Covid-19 cases on April 12, India is witnessing a sharp surge in infections, which is greater in magnitude than what we had faced last year. Despite this, we have been able to
As many as 217 projects worth over Rs 1 lakh crore have been completed under the National Infrastructure Pipeline in the last financial year. Representative Image By Adil Zaidi India sustained stiff lockdowns, deep GDP contractions, supply chain disruptions and still managed to chase the path for economic recuperation. Large parts of the economy have
While the trigger is administration of heparin in HIT, it is the AstraZeneca vaccine that appears to set off this rare reaction in VAPIT. Representative image By K Srinath Reddy A serious but very rare adverse effect. This is the scientific consensus that has emerged after both the European and British regulators examined the association
Some have even suggested that the IMF should wait till “a more accountable government is elected next year.” Representative Image This is perhaps ‘direct democracy’ that governments would dread. Kenyans don’t want the International Monetary Fund (IMF) to lend to their government. To that end, they have been furiously signing online petitions and taking to